Extensive Lung Cancer - Small Cell


Camptosar® plus Paraplatin® Effective for Small Cell Lung Cancer (November 7, 2007)

Camptosar® plus Paraplatin® Effective for Small Cell Lung Cancer According to the results of a study presented at the 12th World Lung Cancer Conference, chemotherapy with Camptosar® (irinotecan) and... Continue Reading

Advances in the Management of Small-Cell Lung Cancer (November 7, 2007)

Advances in the Management of Small-Cell Lung Cancer: Highlights from the 12th World Conference on Lung Cancer Introduction Approximately 25,000 patients are diagnosed with small-cell lung cancer (SCLC)... Continue Reading

Avastin® Added Safely to Paraplatin® and Camptosar® for Small Cell Lung Cancer (November 5, 2007)

Avastin® Added Safely to Paraplatin® and Camptosar® for Small Cell Lung Cancer According to the results of a study presented at the 12th World Conference on Lung Cancer, the targeted therapy Avastin®... Continue Reading

Aranesp® Reduces Blood Transfusions Without Negative Effects on Survival in SCLC (September 18, 2007)

Aranesp® Reduces Blood Transfusions Without Negative Effects on Survival in SCLC According to results recently presented at the 2007 World Conference on Lung Cancer in Seoul, Korea, use of Aranesp® (darbepoetin... Continue Reading

Radiation to the Brain Should Become Standard Therapy for Extensive-disease Small Cell Lung Cancer (August 16, 2007)

Radiation to the Brain Should Become Standard Therapy for Extensive-disease Small Cell Lung Cancer According to results recently published in the New England Journal of Medicine, prophylactic cranial radiation... Continue Reading

Camptosar®/Paraplatin® Improves Survival in Small Cell Lung Cancer (June 12, 2007)

Camptosar®/Paraplatin® Improves Survival in Small Cell Lung Cancer According to results recently presented at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO), the chemotherapy... Continue Reading

Prophylactic Cranial Radiation Improves Survival in Extensive Small-Cell Lung Cancer (June 5, 2007)

Prophylactic Cranial Radiation Improves Survival in Extensive Small-Cell Lung Cancer According to results recently presented at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO),... Continue Reading

Aranesp® Improves Hemoglobin Levels in Lung Cancer Patients (April 27, 2007)

Aranesp® Improves Hemoglobin Levels in Lung Cancer Patients According to results from a Phase III trial, the use of Aranesp® (darbepoetin alfa) in patients with small cell lung cancer (SCLC) being treated... Continue Reading

Dose-intensive Chemotherapy Improves Survival for Patients with Small Cell Lung Cancer (February 2, 2007)

Dose-intensive Chemotherapy Improves Survival for Patients with Small Cell Lung Cancer According to an article recently published in the Journal of Thoracic Oncology, intensified doses of the chemotherapy... Continue Reading

Alimta® Safe and Active in Small Cell Lung Cancer (October 27, 2006)

Alimta® Safe and Active in Small Cell Lung Cancer According to results recently published in the Journal of Clinical Oncology, the addition of the chemotherapy agent Alimta® (pemetrexed) to either Platinol®... Continue Reading

Surgical Removal of Cancer Provides Favorable Survival for Lung Cancer (August 8, 2006)

Surgical Removal of Cancer Provides Favorable Survival for Lung Cancer According to an article recently published in the journal Thorax, the surgical removal of lung cancer (surgical resection) produces... Continue Reading

Radiofrequency Ablation Effective for Lung Cancer or Lung Metastasis (July 26, 2006)

Radiofrequency Ablation Effective for Lung Cancer or Lung Metastasis According to an article recently published in the journal Radiology, radiofrequency ablation (RFA) provides effective anticancer control... Continue Reading

Addition of Thalidomide to Chemotherapy Improves Survival in Small Cell Lung Cancer (June 29, 2006)

Addition of Thalidomide to Chemotherapy Improves Survival in Small Cell Lung Cancer According to results presented at the 2006 annual meeting of the American Society of Clinical Oncology (ASCO), the addition... Continue Reading

Hycamtin® More Convenient than Etoposide in Small Cell Lung Cancer (May 5, 2006)

Hycamtin® More Convenient than Etoposide in Small Cell Lung Cancer According to results recently published in the Journal of Clinical Oncology, the chemotherapy agent Hycamtin® (topotecan) taken orally... Continue Reading

Brain Metastases from Small Cell Lung Cancer Unlikely to Respond to Chemotherapy (May 4, 2006)

Brain Metastases from Small Cell Lung Cancer Unlikely to Respond to Chemotherapy Among small cell lung cancer patients with asymptomatic brain metastases, chemotherapy reduced detectable cancer in the... Continue Reading

Camptosar®/Carboplatin Improves Progression-Free Survival over Etoposide/Carboplatin in Extensive Small-Cell Lung Cancer (April 21, 2006)

Camptosar®/Carboplatin Improves Progression-Free Survival over Etoposide/Carboplatin in Extensive Small-Cell Lung Cancer According to an article published in the Annals of Oncology, the chemotherapy combination... Continue Reading

Addition of G-CSF Reduces Risk of Febrile Neutropenia in Small-Cell Lung Cancer (November 2, 2005)

Addition of G-CSF Reduces Risk of Febrile Neutropenia in Small-Cell Lung Cancer Among patients with small-cell lung cancer, the combination of antibiotics and granulocyte colony-stimulating factor (G-CSF)... Continue Reading

Study Explores Feasibility of High-Dose Chemotherapy and Stem Cell Transplant for Small Cell Lung Cancer (October 26, 2005)

Study Explores Feasibility of High-Dose Chemotherapy and Stem Cell Transplant for Small Cell Lung Cancer According to a study published in the journal Chest, treatment of small cell lung cancer with high-dose... Continue Reading

« Previous PageNext Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS